The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.
Abstract
The role of cGMP in myocardial contraction is not established. Recent reports suggest that nitric oxide, released by endothelial cells or within myocytes, modifies myocardial contraction by raising cGMP. We studied the effects of 8-bromo-cGMP (8bcGMP, 50 mumol/L) on contraction (cell shortening) and simultaneous intracellular Ca2+ transients (indo 1 fluorescence ratio) in intact adult rat ventricular myocytes (0.5 Hz and 25 degrees C) 8bcGMP reduced myocyte twitch amplitude and time to peak shortening (-19.6 +/- 4.2% and -17.6 +/- 1.3%, respectively) and increased steady-state diastolic cell length (+0.6 +/- 0.1 microns, mean +/- SEM, n = 8; all P < .05) but had no effect on shortening velocity, systolic or diastolic fluorescence ratio, or time to peak fluorescence ratio (all P = NS). In 7 of 13 myocytes, this negative inotropic effect was preceded by a transient positive inotropic effect, with small increases in twitch amplitude, shortening velocity, and cytosolic Ca2+ transient. Analysis of 8bcGMP effects on both the dynamic and steady-state relation between cell shortening and intracellular Ca2+ (during twitch contraction and tetanic contraction, respectively) indicated reduction in the myofilament response to Ca2+ in all cases. These 8bcGMP effects were inhibited by KT5823 (1 mumol/L), an inhibitor of cGMP-dependent protein kinase, or by the presence of isoproterenol (3 nmol/L). 8bcGMP had no effect on cytosolic pH in cells (n = 4) loaded with the fluorescent probe carboxyseminaphthorhodafluor-1. These data indicate that cGMP may modulate myocardial relaxation and diastolic tone by reducing the relative myofilament response to Ca2+, probably via cGMP-dependent protein kinase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Thastrup, O., Cullen, P. J., Drøbak, B. K., Hanley, M. R., & Dawson, A. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2466 · Cited by 3,270
ATPase Activity of Myosin Correlated with Speed of Muscle Shortening
Bárány, M. (1967) · The Journal of General Physiology · doi:10.1085/jgp.50.6.197 · Cited by 1,968
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Fabiato, A., & Fabiato, F. (1978) · The Journal of Physiology · doi:10.1113/jphysiol.1978.sp012231 · Cited by 1,090
Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A., & Kaneko, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90293-2 · Cited by 938
Potter, J. D., & Gergely, J. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41347-1 · Cited by 916
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Schulz, R., Nava, E., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09021.x · Cited by 612
Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.
Méry, P. F., Lohmann, S. M., Walter, U., & Fischmeister, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1197 · Cited by 475
Cited by
Nitric oxide signaling in health and disease
Lundberg, J. O., & Weitzberg, E. (2022) · Cell · doi:10.1016/j.cell.2022.06.010 · Cited by 826
Nitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Brutsaert, D. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00017.2002 · Cited by 697
Nitric Oxide and Cardiac Function: Ten Years After, and Continuing
Massion, P. B., Feron, O., Dessy, C., & Balligand, J.-L. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 567
What Mechanisms Underlie Diastolic Dysfunction in Heart Failure?
Kass, D. A., Bronzwaer, J. G. F., & Paulus, W. J. (2004) · Circulation Research · doi:10.1161/01.res.0000129254.25507.d6 · Cited by 480
Balligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Nitric oxide in myocardial ischemia/reperfusion injury
Schulz, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.019 · Cited by 462
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
Krüger, M., Kötter, S., Grützner, A., Lang, P., Andresen, C., Redfield, M. M., Butt, E., dos Remedios, C. G., & Linke, W. A. (2009) · Circulation Research · doi:10.1161/circresaha.108.184408 · Cited by 407
Gauthier, C., Leblais, V, Kobzik, L., Trochu, J. N., Khandoudi, N., Bril, A., Balligand, J. L., & Le Marec, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2191 · Cited by 397
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Regulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385
Self-citationMartin, L., Derwall, M., Al Zoubi, S., Zechendorf, E., Reuter, D. A., Thiemermann, C., & Schuerholz, T. (2019) · Chest · doi:10.1016/j.chest.2018.08.1037 · Cited by 360
Calcium-mediated cell death during myocardial reperfusion
Garcia-Dorado, D., Ruiz-Meana, M., Inserte, J., Rodriguez-Sinovas, A., & Piper, H. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs116 · Cited by 307
A review of sepsis-induced cardiomyopathy
Sato, R., & Nasu, M. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0112-5 · Cited by 306
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Morelli, A., De Castro, S., Teboul, J.-L., Singer, M., Rocco, M., Conti, G., De Luca, L., Di Angelantonio, E., Orecchioni, A., Pandian, N. G., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2619-z · Cited by 303
Recchia, F. A., McConnell, P. I., Bernstein, R. D., Vogel, T. R., Xu, X., & Hintze, T. H. (1998) · Circulation Research · doi:10.1161/01.res.83.10.969 · Cited by 302
“Other studies showed that NO can modulate calcium sensitivity of myofilaments, most likely through an increase in cGMP.(35,36) In particular, some authors have shown that reduced endogenous NO or augmented exogenous NO do decrease or increase, respectively, LV diastolic compliance in vitro and in vivo.”
BackgroundParacrine and autocrine effects of nitric oxide on myocardial function
Shah, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00072-8 · Cited by 293
Self-citationMyocardial Contractile Response to Nitric Oxide and cGMP
Mohan, P., Brutsaert, D. L., Paulus, W. J., & Sys, S. U. (1996) · Circulation · doi:10.1161/01.cir.93.6.1223 · Cited by 281
Vila-Petroff, M. G., Younes, A., Egan, J., Lakatta, E. G., & Sollott, S. J. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1020 · Cited by 272
Self-citationKojda, G., Kottenberg, K., Nix, P., Schlüter, K. D., Piper, H. M., & Noack, E. (1996) · Circulation Research · doi:10.1161/01.res.78.1.91 · Cited by 258
Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy
Prauchner, C. A. (2017) · Burns · doi:10.1016/j.burns.2016.09.023 · Cited by 256
Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
Umar, S., & van der Laarse, A. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0219-x · Cited by 182
Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances
Carlström, M., Weitzberg, E., & Lundberg, J. O. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001060 · Cited by 103
sGCα1β1attenuates cardiac dysfunction and mortality in murine inflammatory shock models
Buys, E. S., Cauwels, A., Raher, M. J., Passeri, J. J., Hobai, I., Cawley, S. M., Rauwerdink, K. M., Thibault, H., Sips, P. Y., Thoonen, R., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2009 · Cited by 49
Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice
Su, J., Zhang, S., Tse, J., Scholz, P. M., & Weiss, H. R. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00316.2003 · Cited by 12
“Significant negative functional effects of cGMP have been observed in ventricular myocytes (6, 23).”
BackgroundHemodynamic characteristics of patients with diastolic heart failure and hypertension.
FUJIMOTO, N., ONISHI, K., DOHI, K., TANABE, M., KURITA, T., TAKAMURA, T., YAMADA, N., NOBORI, T., & ITO, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.1727 · Cited by 11
Metadata
- Authors
- Shah, A. M., Spurgeon, H. A., Sollott, S. J., Talo, A., & Lakatta, E. G.
- Venue
- Circulation Research
- Published
- 1994-05
- Volume
- 74
- Issue
- 5
- Pages
- 970-978
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1979026148
- Cited by
- 377
- References
- 28
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.